AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2025
Feb 18, 2025
30016_dirs_2025-02-18_60478dc9-1a50-49a1-a7cb-a5e9aa329641.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2025-02-13
Reporting Person: FENNELL GEORGE (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-14 | Common Stock | M | 51 | — | Acquired | 8227 | Direct |
| 2025-02-14 | Common Stock | M | 56 | — | Acquired | 8283 | Direct |
| 2025-02-14 | Common Stock | M | 57 | — | Acquired | 8340 | Direct |
| 2025-02-14 | Common Stock | M | 140 | — | Acquired | 8480 | Direct |
| 2025-02-14 | Common Stock | F | 133 | $444.53 | Disposed | 8347 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-13 | Non-Qualified Stock Option (right-to-buy) | $459.76 | A | 3415 | Acquired | 2035-02-12 | Common Stock (3415) | Direct |
| 2025-02-13 | Incentive Stock Option (right-to-buy) | $459.76 | A | 217 | Acquired | 2035-02-12 | Common Stock (217) | Direct |
| 2025-02-13 | Restricted Stock Unit | $ | A | 816 | Acquired | Common Stock (816) | Direct | |
| 2025-02-14 | Restricted Stock Unit | $ | M | 51 | Disposed | Common Stock (51) | Direct | |
| 2025-02-14 | Restricted Stock Unit | $ | M | 56 | Disposed | Common Stock (56) | Direct | |
| 2025-02-14 | Restricted Stock Unit | $ | M | 57 | Disposed | Common Stock (57) | Direct | |
| 2025-02-14 | Restricted Stock Unit | $ | M | 140 | Disposed | Common Stock (140) | Direct |
Footnotes
F1: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026.
F2: Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029.
F3: Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2026.
F4: Each RSU represents a contingent right to receive one share of Issuer. common stock and vested in four annual installments, beginning on February 14, 2022.
F5: Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2023.
F6: Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2024.
F7: Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning on February 14, 2025.